Wiley’s Finest Wild Alaskan Fish Oil is growing rapidly from a small start two years ago, with the messages of sustainability, quality and being 100% USA resonating with American consumers, says the company’s CEO.
Costa Mesa-based Alkemist Labs is expanding its testing capabilities into the omega-3 sector, with the success of its label claim verification/ R&D division allowing for continued reinvestment.
DSM has delivered a Q3 increase in EBITDA earnings of 27% across all its divisions despite “headwinds” like the ongoing economic flatline in Europe and elsewhere, challenging currency movements and rising ingredient costs.
Blood levels of DHA and other omega-3s are directly related to measures of cognition and behavior in schoolchildren with below average reading ability, says a new study from the UK.
Epax CEO Ola Snove thinks the €2bn BASF and DSM buying frenzy that saw many major suppliers consolidated in their hands is ultimately a good thing for the €20bn+ sector – but its independence remains valued at Epax.
DSM says the supply bottleneck in fish-sourced omega-3 that recently forced its own prices up 15%, is not confined to the dominant source – Peruvian anchovies.
DSM’s bulging lipid business has bumped fish-sourced omega-3 oil prices 15% as crude fish oil stock prices skyrocket in the face of increasing demands on global fisheries.
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.
The growth in branded omega-3 product has been great for ‘professionalizing’ the industry, says the CEO of EPAX, and the arrival of ‘Big Pharma’ and FMCG companies will be good for standards.
Royal DSM has emphasised “business continuity” and “smooth integration” following the completion of its $CAD540m (€436m) buy-out of the world’s largest omega-3 fish oil supplier, Ocean Nutrition Canada (ONC), today.
Increased levels of the omega-3 DHA may be associated with improved literacy in children with learning difficulties, according to a new study from Australia.
DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.
High intake of the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) could help protect the aging brain, according to research.
A fish oil supplement enriched with DHA may benefit early communicative development in infants, says the first randomized controlled trial testing high dose omega-3 on brain development in non-premature infants
With the volume of omega-3 science tripling in 10 years, the world’s leading omega-3 trade group is working with international regulators to have that research reflected in authorised claims – especially in the EU and the US.
Omega-3 supplier Golden Omega is finalizing it $60 million state-of-the-art omega-3 fish oil processing plant in northern Chile, and promises to compete on quality, concentration, and price.
US troops and service personnel with low levels of omega-3 are at increased risk of suicide, says a new study that potential opens the door to widespread omega-3 supplementation.
The dynamics of the algal omega-3 market are set to change over the next 18 months with the entrance of two new players both promising to trump the competition in the efficiency and sustainability stakes.
A new player is poised to enter the vegetarian omega-3 market with a production process it claims will enable it to make the long chain fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) from algae at a fraction of the cost of rivals.
Martek expects sales of its algal-sourced omega-3s to food and drink manufacturers to grow in the double-digits each year for the next four to five years as it broadens its product range and gains access to new markets and customers post its takeover...
High doses of the omega-3 fatty acid DHA in baby formula or breast milk may have ‘modest, positive effects’ on the growth of the pre-term infants, including increased length, says a new study from Australia.
Royal DSM has kicked the integration of its new €800m wholly-owned subsidiary, Martek Biosciences Corporation, into life by establishing a special integration unit to manage the US-Dutch-Swiss deal.
Supplements of the omega-3 fatty acid DHA (docosahexanoic acid) may prevent traumatic brain injury, according to a new study with rats with potential implications for sportsmen and soldiers.
Daily supplements of docosahexaenoic acid (DHA) were ‘not useful’ in reducing cognitive decline associated with mild-to-moderate Alzheimer’s disease, says a new study.
Martek Biosciences is to sell off the majority of its manufacturing plant in Winchester to animal health company Alltech as part of a restructuring plan, but will retain some R&D and limited production capacity at the site.
The Global Organization for EPA and DHA (GOED) has expanded its board of directors from eight to 14 to represent growth in the association’s recent membership.
Omega-3 producer Martek Biosciences Corporation has signed a multi-year agreement to to fortify Feihe Dairy’s new premium infant formula and growing-up milk products with DHA and ARA for sale in China.
Global DHA leader Martek Biosciences Corporation has signed a deal to supply Feihe Dairy in China with DHA and ARA for the American Dairy-owned operation’s new infant formula and follow-on milks.
Martek is set to give greater focus to DHA (Docosahexaenoic Acid) products targeted at older adults after a study published this week confirmed the brain health benefits of DHA consumption for that segment of the population.
Global omega-3 DHA leader Martek Biosciences Corporation has launched its life'sDHA ingredient in China after signing a five-year deal with local dairy, Mengniu.
The USDA’s National Organic Program (NOP) is reviewing the approval for omega-3 fatty acid DHA and omega-6 fatty acid ARA to be included in infant formula or baby foods that are certified as organic because, it says, the ingredients have not received...
DuPont has launched a dietary supplement range in the US that employs its high-dose, yeast-derived EPA ingredient that is targeting younger consumers seeking vegetarian alternatives.
The first cooking oil fortified with the omega-3 fatty acid DHA is now available in China thanks to a new partnership between US company Martek Biosciences Corporation and local food manufacturer and trading group COFCO Food Sales & Distribution.
Maryland-based Martek Biosciences will make its debut in the EPA market with an EPA/DHA blend “by year’s end”, NutraIngredients-USA.com learnt at Expo West last week.
First quarter revenue for 2010 rose three percent to $89.8m at Maryland-based DHA specialist Martek Biosciences Corporation, with revenue jumping eight percent to $10.4m when costs associated with its acquisition of Amerifit Brands were discounted.
Supplements of the omega-3 fatty acid DHA (docosahexaenoic acid) may alter the function of the brain associated with working memory, according to results of a new study with healthy boys.
Illinois-based food multinational, Sara Lee, has made its first leap into the functional bakery, omega-3 space with a DHA-fortified white bread aimed at children that has been backed by the Disney Corporation.
